Solid Biosciences LLC Asset Resilience Ratio

Latest as of June 2026: 51.90%

Solid Biosciences LLC asset resilience ratio. Solid Biosciences LLC (SLDB) has an Asset Resilience Ratio of 51.90% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Solid Biosciences LLC (SLDB) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$218.28 Million

Cash + Short-term Investments

Total Assets

$420.58 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Solid Biosciences LLC (2015–2025)

Asset resilience ratio of Solid Biosciences LLC from 2015 to 2025. This chart shows how Solid Biosciences LLC's Asset Resilience Ratio has changed over time. Read Solid Biosciences LLC (SLDB) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Solid Biosciences LLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Solid Biosciences LLC (SLDB) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$218.28 Million	51.9%
Total Liquid Assets	$218.28 Million	51.90%

Asset Resilience Insights

Very High Liquidity: Solid Biosciences LLC maintains exceptional liquid asset reserves at 51.90% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Solid Biosciences LLC Industry Peers by Asset Resilience Ratio

Compare Solid Biosciences LLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Solid Biosciences LLC Asset Resilience Ratio by Year (2015–2025)

Solid Biosciences LLC asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Solid Biosciences LLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	55.02%	$127.95 Million	$232.54 Million	+18.62pp
2024-12-31	36.41%	$68.69 Million	$188.66 Million	+6.32pp
2023-12-31	30.09%	$49.62 Million	$164.94 Million	+7.67pp
2022-12-31	22.42%	$58.34 Million	$260.25 Million	-15.73pp
2021-12-31	38.15%	$88.64 Million	$232.38 Million	--
2020-12-31	0.00%	$0.00	$171.17 Million	--
2019-12-31	7.23%	$7.48 Million	$103.47 Million	-18.63pp
2018-12-31	25.86%	$36.10 Million	$139.60 Million	+3.53pp
2017-12-31	22.33%	$17.01 Million	$76.19 Million	-51.45pp
2016-12-31	73.78%	$29.98 Million	$40.64 Million	+25.67pp
2015-12-31	48.10%	$26.79 Million	$55.70 Million	--

pp = percentage points

About Solid Biosciences LLC

NASDAQ:SLDB USA Biotechnology

Market Cap

$673.37 Million

Market Cap Rank

#10380 Global

#2795 in USA

Share Price

$6.28

Change (1 day)

+4.67%

52-Week Range

$3.93 - $11.15

All Time High

$775.50